Novanta Inc. (NOVT)
NASDAQ: NOVT · Real-Time Price · USD
127.43
+1.10 (0.87%)
Jun 6, 2025, 2:31 PM - Market open
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 28, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
| Automation Enabling Technologies | 496.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Automation Enabling Technologies Growth | 1.59% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Solutions Revenue (Post-Q3 2024 Reporting) | 455.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Solutions Revenue (Post-Q3 2024 Reporting) Growth | 12.46% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Precision Medicine and Manufacturing | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Precision Medicine and Manufacturing Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Solutions Revenue (Pre-Q4 2024 Reporting) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Solutions Revenue (Pre-Q4 2024 Reporting) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Robotics and Automation | 303.68M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Robotics and Automation Growth | 14.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 28, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
| Automation Enabling Technologies Operating Income | 113.96M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Automation Enabling Technologies Operating Income Growth | 17.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Solutions Operating Income (Post-Q3 2024 Reporting) | 55.54M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Solutions Operating Income (Post-Q3 2024 Reporting) Growth | -13.64% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Precision Medicine and Manufacturing Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Precision Medicine and Manufacturing Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Solutions Operating Income (Pre-Q4 2024 Reporting) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Solutions Operating Income (Pre-Q4 2024 Reporting) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Robotics and Automation Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Robotics and Automation Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate and Shared Services Operating Income | -52.11M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate and Shared Services Operating Income Growth | 1.83% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Gross Income by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 28, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
| Automation Enabling Technologies Gross Profit | 238.86M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Automation Enabling Technologies Gross Profit Growth | 7.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Solutions Gross Profit (Post-Q3 2024 Reporting) | 189.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Solutions Gross Profit (Post-Q3 2024 Reporting) Growth | -0.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Precision Medicine and Manufacturing Gross Profit | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Precision Medicine and Manufacturing Gross Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Solutions Gross Profit (Pre-Q4 2024 Reporting) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Solutions Gross Profit (Pre-Q4 2024 Reporting) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Robotics and Automation Gross Profit | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Robotics and Automation Gross Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate and Shared Services Gross Profit | -3.07M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate and Shared Services Gross Profit Growth | -24.08% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 28, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
| United States | 493.68M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 14.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany | 118.54M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany Growth | -6.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe | 129.68M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe Growth | -6.46% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 88.93M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 22.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Asia-Pacific | 103.18M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Asia-Pacific Growth | -1.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Geographic | 17.69M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Geographic Growth | -9.52% |
Log In |
Log In |
Log In |
Log In | Upgrade
|